Cancer scientists overestimate the extent to which high-profile preclinical studies can be successfully replicated, new research from 不良研究所 suggests.
Category:
Published on: 29 Jun 2017
Cancer scientists overestimate the extent to which high-profile preclinical studies can be successfully replicated, new research from 不良研究所 suggests.